Atlas Trials

Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea

Clinical trial NCT02922231 · COMPLETED

Trial details

NCT number
NCT02922231
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Study type
OBSERVATIONAL
Hemophilia B
Start date
2017-01-06
Primary completion
2019-04-04
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.